← Back to Search

Behavioral Intervention

Technology-Based Care Intervention for Hospice Care

N/A
Recruiting
Led By Veerawat Phongtankuel, MD, MS
Research Sponsored by Weill Medical College of Cornell University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
65 years of age or older
18 years of age or older
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1, 2, 3, 4, 5, 6 weeks
Awards & highlights

Study Summary

This trial will test if a technology-based care intervention can improve home hospice care for older adults.

Who is the study for?
This trial is for English-speaking adults over 18 who are not blind and have a family member aged 65 or older receiving home hospice care. It excludes patients with dementia or cognitive impairments that prevent informed consent.Check my eligibility
What is being tested?
The study is testing I-HoME, a technology-based intervention designed to improve management of end-of-life issues in home hospice care through the use of structured educational videos and other tech tools.See study design
What are the potential side effects?
Since this intervention involves non-medical technology and education, traditional physical side effects are not expected; however, there may be emotional or psychological impacts due to the nature of end-of-life care discussions.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 65 years old or older.
Select...
I am 18 years old or older.
Select...
I am in home hospice care and am not blind.
Select...
I am in home hospice care and speak English.
Select...
I am 65 or older and receiving care at home for a terminal illness.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1, 2, 3, 4, 5, 6 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1, 2, 3, 4, 5, 6 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Feasibility measurement 2
Feasibility measurement 3
Feasibility measurement 4
+5 more
Secondary outcome measures
Change in caregiver burden as measured by the Zarit Burden Interview - short form
Change in symptom burden as measured by the Edmonton Symptom Assessment Scale
Number of patient hospitalizations

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: I-HoME interventionExperimental Treatment1 Intervention
Weekly televisits with a nurse practitioner that will implement the I-HoME intervention.
Group II: Control armActive Control1 Intervention
Standard of care.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
I-HoME
2021
N/A
~20

Find a Location

Who is running the clinical trial?

Weill Medical College of Cornell UniversityLead Sponsor
1,055 Previous Clinical Trials
1,316,075 Total Patients Enrolled
Visiting Nurse Service of New YorkOTHER
11 Previous Clinical Trials
5,161 Total Patients Enrolled
National Institute on Aging (NIA)NIH
1,675 Previous Clinical Trials
28,020,705 Total Patients Enrolled

Media Library

I-HoME (Behavioral Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT04243538 — N/A
Hospice Research Study Groups: Control arm, I-HoME intervention
Hospice Clinical Trial 2023: I-HoME Highlights & Side Effects. Trial Name: NCT04243538 — N/A
I-HoME (Behavioral Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04243538 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there still vacant spots available for this research endeavor?

"Affirmative. According to information hosted on clinicaltrials.gov, this medical trial is actively recruiting participants from one center after it was first posted on February 14th 2022 and last updated March 25th 2022. 220 patients are needed for the study in total."

Answered by AI

What type of individuals are best suited to joining this research project?

"This study seeks to enroll 220 individuals aged 18-110 who are receiving hospice care. Furthermore, applicants must have a family member in home hospice care, be at least 65 years old, not visually impaired, and currently enrolled in some type of home hospice program."

Answered by AI

To what capacity is this clinical trial accepting participants?

"Affirmative. According to clinicaltrials.gov, this medical trial opened for recruitment on February 14th 2022 and is still active today. It requires 220 participants from a single site."

Answered by AI

Does the research permit elderly individuals to participate?

"The criteria for this trial stipulates that only those over the age of consent and under 110 are qualified to enroll."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
Piloting a Multi-component Technology-based Care Intervention to Address Patient Symptoms in Home Hospice
2022. "Piloting a Multi-component Technology-based Care Intervention to Address Patient Symptoms in Home Hospice". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04243538.
~16 spots leftby Jun 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top